Is there a disparity in osteoporosis referral and treatment among people with affective disorders? A ten-year data linkage study

<p dir="ltr">Aims: People with affective disorders (AD) are at increased risk of osteoporosis and fractures. Osteoporosis treatment/referral is thus essential in this population. However, it is unclear whether osteoporosis treatment/referral differs between those with and without AD. This retrospective cohort study compared osteoporosis treatment/referral in people with and without AD across linked primary and mental health care data.</p><p dir="ltr">Methods: People with AD (ICD-10 codes F3*) between 1.5.2009–30.11.2019, aged 18+ at first diagnosis, from Lambeth, South London were randomly matched 1:4 to healthy controls based on age band and gender. Outcomes including treatments (prescription of calcium, calcium with vitamin D) and referral (referrals for osteoporosis screening and/or prevention) were analysed using conditional and multivariable logistic regression analyses.</p><p dir="ltr">Results: People with AD (<i>n</i> = 23,932) were more likely than controls (<i>n</i> = 76,593) to have a recorded prescription of calcium (odds ratio [OR] = 1.64, 95 % confidence interval [CI] 1.40–1.92) and calcium with vitamin D (OR = 2.25, 95 % CI 2.10–2.41), and be referred for osteoporosis screening (OR = 1.87, 95 % CI 1.76–1.99) within 2 years after the date of the first AD diagnosis in adjusted analyses. Older age, female sex, having an ethnic minority background, Class A analgesics use were significant predictors for all osteoporosis management pathways within AD patients.</p><p dir="ltr">Conclusion: Findings from the present study suggest that compared to the general population, people with AD are more likely to receive osteoporosis screening/treatments. Whether this increased screening/treatment is sufficient to reduce the burden of osteoporosis and fractures in this population is unclear and warrants further consideration.</p>